As stated by the FDA recommendation, the two medications treatment for use against 2009 H1N1 influenza virus are 
Tamiflu (oseltamivir phosphate) and Relenza (zanamivir). In this article, we provide you with all the informations about RELENZA® an FDA Recommendation for H1N1 Influenza Treatment and Prophylaxis.
The content of this article consists such of indications of usage, dosage and administrations, warning and precautions, drug interactions, how supplie or handling storage and etc. Accordingly, this RELENZA® for treatment is indicated for patients in 7 years of ages and/or older who have been signed for influenza symtoms for no more than 2 days. RELENZA® for prophylaxys is indicated in patients 5 years of age and/or older.
Find detailed information associated with RELENZA® as an FDA Recommendation for H1N1 Influenza Treatment and Prophylaxis in 29 pages, 1.3 Mb of pdf filetype available (source: fda.gov)
